Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NBIX | NEUROCRINE BIOSCIENCES INC | $13.94B | $138.48 | $159.06 | 14.86% | Strong Buy | 16 | 14.74% | 35.79% | N/A | N/A | ||||
| SRPT | SAREPTA THERAPEUTICS INC | $12.54B | $132.66 | $162.77 | 22.70% | Strong Buy | 13 | 28.07% | 153.38% | N/A | N/A | ||||
| FENC | FENNEC PHARMACEUTICALS INC | $200.54M | $7.34 | $18.00 | 145.23% | Buy | 2 | 27.65% | 159.90% | N/A | N/A | ||||
| TGTX | TG THERAPEUTICS INC | $2.78B | $17.96 | $31.20 | 73.72% | Strong Buy | 5 | 28.50% | 61.87% | N/A | N/A | ||||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.70B | $29.86 | $39.80 | 33.29% | Hold | 5 | 15.57% | 38.33% | N/A | N/A | ||||
| CORT | CORCEPT THERAPEUTICS INC | $2.88B | $27.66 | $40.67 | 47.02% | Strong Buy | 3 | 13.45% | 24.89% | N/A | N/A | ||||
| INCY | INCYTE CORP | $12.81B | $57.05 | $74.92 | 31.33% | Buy | 13 | 10.20% | 41.93% | N/A | N/A | ||||
| CPRX | CATALYST PHARMACEUTICALS INC | $1.95B | $16.49 | $27.80 | 68.59% | Strong Buy | 5 | 15.07% | 20.89% | N/A | N/A | ||||
| HALO | HALOZYME THERAPEUTICS INC | $5.58B | $43.82 | $54.00 | 23.23% | Buy | 6 | 14.41% | 41.76% | N/A | N/A | ||||
| RPRX | ROYALTY PHARMA PLC | $16.77B | $28.07 | $43.33 | 54.37% | Strong Buy | 3 | 14.10% | 60.66% | N/A | N/A | ||||
| GMAB | GENMAB A | $19.53B | $29.53 | $45.00 | 52.39% | Buy | 4 | 18.93% | 37.91% | N/A | N/A | ||||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $15.12B | $79.65 | $102.00 | 28.06% | Buy | 11 | 11.22% | 81.99% | N/A | N/A | ||||
| MNKD | MANNKIND CORP | $1.23B | $4.50 | $7.00 | 55.56% | Strong Buy | 2 | 16.05% | 132.08% | N/A | N/A | ||||
| HCM | HUTCHMED (CHINA) LTD | $3.73B | $21.40 | $22.10 | 3.27% | Strong Buy | 1 | 4.03% | 33.58% | N/A | N/A | ||||
| TECH | BIO-TECHNE CORP | $13.26B | $84.15 | $80.71 | -4.08% | Strong Buy | 7 | 6.18% | 33.92% | N/A | N/A | ||||
| EXEL | EXELIXIS INC | $6.11B | $20.99 | $26.78 | 27.58% | Buy | 9 | 7.83% | 56.43% | N/A | N/A | ||||
| PBYI | PUMA BIOTECHNOLOGY INC | $238.30M | $4.94 | $7.00 | 41.70% | Buy | 1 | 2.20% | 67.87% | N/A | N/A | ||||
| BNTX | BIONTECH SE | $21.94B | $92.28 | $111.88 | 21.23% | Hold | 8 | 0.97% | 175.42% | N/A | N/A | ||||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $7.06B | $112.01 | $190.55 | 70.11% | Strong Buy | 11 | 6.61% | 77.12% | N/A | N/A | ||||
| NVO | NOVO NORDISK A S | $599.47B | $132.92 | $133.00 | 0.06% | Strong Buy | 6 | 19.78% | 2.84% | N/A | N/A | ||||
| UTHR | UNITED THERAPEUTICS CORP | $11.97B | $269.78 | $317.17 | 17.57% | Buy | 6 | 7.17% | 6.59% | N/A | N/A | ||||
| REGN | REGENERON PHARMACEUTICALS INC | $108.49B | $984.64 | $1.04k | 5.75% | Buy | 14 | 7.20% | 5.74% | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.